Attention Mechanism with Bayesian Decision Theory for Drug Prediction

Biomedical literature lacks integration of dynamic drug interaction data for personalized prescriptions. This proposed work is a new hybrid model that enhances drug safety prescriptions by taking into account individual patient features and drug interactions. It does this by hybrid attention mechanisms with Bayesian Decision Theory (BDT), which employs Bayesian statistical thinking instead of the dot-product approach. This approach is driven by the growing complexity of patient profiles and the limitations of current algorithms, which often fail to dynamically change the relevance of individual aspects. This method seeks 94% accuracy, effectively prioritizing safer drug combinations and personalizing drug recommendations. This integration leads to more consistent and customized drug prescriptions, which ultimately improve patient outcomes and advance the field of personalized healthcare.